Table 6

Levels and reducing percentage of LDL-C, dosage and duration in different statin group
Group N Age MeanLDL-C at Baseline (mg) MeanLDL-C at Follow up (mg) Mean Reducing percentage Statin dosage (mg) Duration (month)
Rosuvastatin 1173 58.1±1.8 123.9±8.6 63.3±7.4 48.4±4.2 33.3±11.6 20.5±6.3
Atorvastatin 1138 58.4±2.5 128.0±14.0 73.0±8.7 42.3±3.7 60.3±28.6 17.5±7.1
Pitavastatin 125 62.5±11.5 130.9±33.3 81.1±23.4 36.2±19.5 4 8~12
Fluvastatin 40 63.0±10.0 144.9±31.5 98.1±12.7 32.3 60 12
Simvastatin 90 57.9±0.1 136.61±5.3 81.2±3.5 39.9±6.1 28.9±10.0 17.8±6.5
Pravastatin 319 58.2±3.2 146.8±7.4 108.9±2.9 24.6±2.6 34.8±9.9 15.4±5.0

Gao et al.

Gao et al. BMC Cardiovascular Disorders 2014 14:60   doi:10.1186/1471-2261-14-60

Open Data